Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients

NCT00990314 is registered in ClinicalTrials.gov with Lung Biotechnology PBC as lead sponsor.

NCT NCT00990314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00990314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients
Lead sponsor
Lung Biotechnology PBC
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2009
Completion date
November 30, 2013
Enrollment
31 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension